MetaADEDB 2.0 @ LMMD
Deamino Arginine Vasopressin
(MLSVJHOYXJGGTR-IFHOVBQLSA-N)
Structure
SMILES
NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)CCSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O.CC(=O)O
Molecular Formula:
C48H68N14O14S2
Molecular Weight:
1129.270
Log P:
1.6144
Hydrogen Bond Acceptor:
30
Hydrogen Bond Donor:
14
TPSA:
525.81
CAS Number(s):
62288-83-9
Synonym(s)
1.
Deamino Arginine Vasopressin
2.
Desmopressin
3.
Vasopressin, Deamino Arginine
4.
1-Deamino-8-D-arginine Vasopressin
5.
1-Desamino-8-arginine Vasopressin
6.
Adiuretin
7.
Adiuretin SD
8.
Apo-Desmopressin
9.
DDAVP
10.
Desmogalen
11.
Desmopressin Acetate
12.
Desmopressin Monoacetate
13.
Desmopressin Monoacetate, Trihydrate
14.
Desmopressine Ferring
15.
Desmospray
16.
Desmotabs
17.
Minirin
18.
Minurin
19.
Nocutil
20.
Octim
21.
Octostim
22.
Acetate, Desmopressin
23.
Arginine Vasopressin, Deamino
24.
Ferring, Desmopressine
25.
Monoacetate, Desmopressin
26.
Monoacetate, Trihydrate Desmopressin
27.
Trihydrate Desmopressin Monoacetate
28.
Vasopressin, 1-Deamino-8-D-arginine
29.
Vasopressin, 1-Desamino-8-arginine
External Link(s)
MeSHD003894
PubChem Compound9833407
BindingDB50247923
CHEMBLCHEMBL1200556
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 51US FAERS
2HeadacheFAERS: 17US FAERS
3VomitingFAERS: 11US FAERS
4Blood sodium decreasedFAERS: 10US FAERS
5Water IntoxicationFAERS: 9US FAERS
6OverdoseFAERS: 8US FAERS
7Pharmaceutical product complaintFAERS: 8US FAERS
8Osmotic demyelination syndromeFAERS: 7US FAERS
9Abdominal PainFAERS: 6US FAERS
10Incorrect dose administeredFAERS: 6US FAERS
11Arterial thrombosisFAERS: 5US FAERS
12Medication ErrorFAERS: 5US FAERS
13NauseaFAERS: 5US FAERS
14Budd-Chiari SyndromeFAERS: 4US FAERS
15DehydrationFAERS: 4US FAERS
16Depressed Level of ConsciousnessFAERS: 4US FAERS
17Electrolyte imbalanceFAERS: 4US FAERS
18MalaiseFAERS: 4US FAERS
19Memory impairmentFAERS: 4US FAERS
20Mental status changesFAERS: 4US FAERS
21Product substitution issueFAERS: 4US FAERS
22Abdominal discomfortFAERS: 3US FAERS
23Altered state of consciousnessFAERS: 3US FAERS
24AscitesFAERS: 3US FAERS
25Blood sodium increasedFAERS: 3US FAERS
26EpistaxisFAERS: 3US FAERS
27Feeling abnormalFAERS: 3US FAERS
28Incorrect storage of drugFAERS: 3US FAERS
29Product container issueFAERS: 3US FAERS
30SomnolenceFAERS: 3US FAERS
31ThirstFAERS: 3US FAERS
32Troponin increasedFAERS: 3US FAERS
33Unresponsive to stimuliFAERS: 3US FAERS
34Accidental overdoseFAERS: 2US FAERS
35AlopeciaFAERS: 2US FAERS
36AstheniaFAERS: 2US FAERS
37Atrial thrombosisFAERS: 2US FAERS
38Blood lactate dehydrogenase increasedFAERS: 2US FAERS
39Chest PainFAERS: 2US FAERS
40Chest discomfortFAERS: 2US FAERS
41Deep Vein ThrombosisFAERS: 2US FAERS
42DeliriumFAERS: 2US FAERS
43Diabetes InsipidusFAERS: 2US FAERS
44DizzinessFAERS: 2US FAERS
45Drug dose omissionFAERS: 2US FAERS
46Drug effect incompleteFAERS: 2US FAERS
47Drug ineffective for unapproved indicationFAERS: 2US FAERS
48Facial ParesisFAERS: 2US FAERS
49FlushingFAERS: 2US FAERS
50HepatosplenomegalyFAERS: 2US FAERS
51HypotensionFAERS: 2US FAERS
52Incorrect route of drug administrationFAERS: 2US FAERS
53No adverse eventFAERS: 2US FAERS
54PolyuriaFAERS: 2US FAERS
55Precocious PubertyFAERS: 2US FAERS
56Product quality issueFAERS: 2US FAERS
57Product use issueFAERS: 2US FAERS
58Pulmonary EmbolismFAERS: 2US FAERS
59RhabdomyolysisFAERS: 2US FAERS
60ThrombosisFAERS: 2US FAERS
61Transaminases increasedFAERS: 2US FAERS
62Urinary IncontinenceFAERS: 2US FAERS
63Urine output increasedFAERS: 2US FAERS
64Wrong drug administeredFAERS: 2US FAERS
65nervous system disorderFAERS: 2US FAERS
66Angina PectorisFAERS: 1US FAERS
67AnxietyFAERS: 1US FAERS
68Aortic Valve StenosisFAERS: 1US FAERS
69ApathyFAERS: 1US FAERS
70Apparent life threatening eventFAERS: 1US FAERS
71Blood bilirubin unconjugated increasedFAERS: 1US FAERS
72Blood cortisol decreasedFAERS: 1US FAERS
73Blood creatine phosphokinase increasedFAERS: 1US FAERS
74Blood creatinine decreasedFAERS: 1US FAERS
75Blood electrolytes abnormalFAERS: 1US FAERS
76Blood osmolarity decreasedFAERS: 1US FAERS
77Blood osmolarity increasedFAERS: 1US FAERS
78Blood potassium increasedFAERS: 1US FAERS
79Body temperature fluctuationFAERS: 1US FAERS
80BradyphreniaFAERS: 1US FAERS
81Burning sensationFAERS: 1US FAERS
82Cardiac ArrestFAERS: 1US FAERS
83Cardiac asthmaFAERS: 1US FAERS
84CataractFAERS: 1US FAERS
85Cerebral hygromaFAERS: 1US FAERS
86Cerebral salt-wasting syndromeFAERS: 1US FAERS
87Cerebrovascular accidentFAERS: 1US FAERS
88ChokingFAERS: 1US FAERS
89Coagulation factor VIII level increasedFAERS: 1US FAERS
90Colonic Pseudo-ObstructionFAERS: 1US FAERS
91Coronary Artery DiseaseFAERS: 1US FAERS
92CystitisFAERS: 1US FAERS
93Device malfunctionFAERS: 1US FAERS
94Diabetes MellitusFAERS: 1US FAERS
95DisorientationFAERS: 1US FAERS
96DiverticulitisFAERS: 1US FAERS
97Drug ToleranceFAERS: 1US FAERS
98Drug dispensing errorFAERS: 1US FAERS
99Drug effective for unapproved indicationFAERS: 1US FAERS
100DysarthriaFAERS: 1US FAERS
101DysphoniaFAERS: 1US FAERS
102DysuriaFAERS: 1US FAERS
103Electroencephalogram abnormalFAERS: 1US FAERS
104EncephalitisFAERS: 1US FAERS
105EnuresisFAERS: 1US FAERS
106EpilepsyFAERS: 1US FAERS
107Excessive eye blinkingFAERS: 1US FAERS
108Excessive masturbationFAERS: 1US FAERS
109Expired product administeredFAERS: 1US FAERS
110Extra dose administeredFAERS: 1US FAERS
111General physical condition abnormalFAERS: 1US FAERS
112HordeolumFAERS: 1US FAERS
113HypersensitivityFAERS: 1US FAERS
114HypersomniaFAERS: 1US FAERS
115Hypertrophic CardiomyopathyFAERS: 1US FAERS
116Hypoaesthesia facialFAERS: 1US FAERS
117Hyponatraemic seizureFAERS: 1US FAERS
118HypothyroidismFAERS: 1US FAERS
119Immune thrombocytopenic purpuraFAERS: 1US FAERS
120IncontinenceFAERS: 1US FAERS
121Incorrect dose administered by deviceFAERS: 1US FAERS
122Increased upper airway secretionFAERS: 1US FAERS
123InfluenzaFAERS: 1US FAERS
124Infusion site painFAERS: 1US FAERS
125Intervertebral disc disorderFAERS: 1US FAERS
126LethargyFAERS: 1US FAERS
127LymphadenopathyFAERS: 1US FAERS
128Multiple allergiesFAERS: 1US FAERS
129Myoglobin blood increasedFAERS: 1US FAERS
130Nasal discomfortFAERS: 1US FAERS
131NocturiaFAERS: 1US FAERS
132OliguriaFAERS: 1US FAERS
133Oral contusionFAERS: 1US FAERS
134Oropharyngeal painFAERS: 1US FAERS
135PallorFAERS: 1US FAERS
136Pericardial effusionFAERS: 1US FAERS
137Peripheral swellingFAERS: 1US FAERS
138PeritonitisFAERS: 1US FAERS
139Pharyngolaryngeal PainFAERS: 1US FAERS
140PolydipsiaFAERS: 1US FAERS
141Poor quality sleepFAERS: 1US FAERS
142Post procedural complicationFAERS: 1US FAERS
143Procedural complicationFAERS: 1US FAERS
144Product administration errorFAERS: 1US FAERS
145Product dose omissionFAERS: 1US FAERS
146Product label confusionFAERS: 1US FAERS
147Product label issueFAERS: 1US FAERS
148Product storage errorFAERS: 1US FAERS
149Pulmonary HypertensionFAERS: 1US FAERS
150QuadriparesisFAERS: 1US FAERS
151Respiratory distressFAERS: 1US FAERS
152RetchingFAERS: 1US FAERS
153Salt cravingFAERS: 1US FAERS
154ScabFAERS: 1US FAERS
155ShockFAERS: 1US FAERS
156SinusitisFAERS: 1US FAERS
157Slow response to stimuliFAERS: 1US FAERS
158StressFAERS: 1US FAERS
159SyncopeFAERS: 1US FAERS
160Therapeutic response unexpectedFAERS: 1US FAERS
161Therapy non-responderFAERS: 1US FAERS
162ThrombocytopeniaFAERS: 1US FAERS
163Thrombotic cerebral infarctionFAERS: 1US FAERS
164Tooth InfectionFAERS: 1US FAERS
165TremorFAERS: 1US FAERS
166Unevaluable eventFAERS: 1US FAERS
167Urinary tract infectionFAERS: 1US FAERS
168UrticariaFAERS: 1US FAERS
169Ventricular hypertrophyFAERS: 1US FAERS
170Von Willebrand's factor antigen increasedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.